Let’s meet in Miami

Understand how you can transform market access performance and achieve excellence in market access and pricing with our latest digital innovations. 

Join us on Day 2, 11:45 to hear from our team on:

Transform Market Access Tracking with Access Hub™

The process of launching a new drug globally is complex and time-consuming, involving negotiations and approvals in multiple countries. To support this endeavour, an often small Global Market Access team collaborate with their country counterparts to facilitate the launch around the world. 

Many companies continue to face challenges due to reliance on tools like Excel, PowerPoint, and email as the primary collaboration channels. These outdated methods result in delayed and inconsistent access to data, limited collaboration, and ineffective tracking of key metrics.

To address these issues we launched Access Hub, an all-in-one digital market access dashboard and performance tracking tool, that’s been designed specifically for market access teams.

Through extensive user research, we have built an innovative online platform that centralises launch activity tracking, streamlines communication, fosters information sharing and captures essential KPIs.

Access Hub revolutionises global drug launches by empowering teams to make informed decisions, learn from past experiences, benchmark against competition, and showcase the success of their brands.

In this session our Head of Sales, Russ Leslie, will walk through Access Hub and how it’s supporting the most successful pharma companies to transform how they track market access performance.  

Get to know the Access Infinity team

Meet the team

Russ Leslie

Head of Sales

robert buckley

Senior Business Development Manager

Robert Buckley

Senior Business Development Manager

Thomas Gilboy

Product Owner

Margaret Labban

Product Manager

Join us on Day 2, __to hear from our team on:

Question statement

Our presentation on day 2 will focus on the needs of early market access teams, taking a deeper dive into how to produce more accurate analysis and evidence to support a product’s launch strategy, at pace.

In today’s pharma companies, the Market Access and Pricing function is providing a vital bridge between clinical and commercial functions. Analogues need to be considered at every stage, so that influencing drivers for price and market access can be evaluated.

In this session, our Founding Director Shri Rao Mukku will explore best practices in analysing analogues, as well as uncover the common mistakes we see in industry, offering our advice for how to avoid them.

Join the Access Infinity team at RAI Congress Centre Amsterdam 21st – 23rd March.

Best practices in estimating pipeline product prices for early market access teams

It goes without saying that analogues are a great choice for robust evidence because they tell us what’s historically happened to products in similar situations. Of course, there is no perfect analogue that 100% meets your own product, so how do you choose which ones to analyse and review?
There’s much to consider and a lot at stake, not to mention the time pressures you’re facing to answer complex questions, at pace.
So how can early market access professionals take a holistic approach to finding the right analogues in the right time frame?
Our Product Owner Thomas Gilboy explores this at EPA Congress, taking a deeper dive into:
· The analogue analysis challenges faced by today’s early market access teams[LB1]
· How to produce more accurate analysis and evidence to support a product’s launch strategy
· How to pick up the pace of analogue analysis [LB2] so that you can respond rapidly and accurately to enquiries from the [launch?] team

Let’s meet in person

The World EPA Congress 2022 is a great opportunity to share ideas. Block some time for a product demo or chat with our P&MA experts. We look forward to seeing you in Amsterdam.

Meet us at Booth 20.

About Access Infinity

Access Infinity is the world leader of digital transformation in the Pharma Industry. We are a trusted provider of digital platforms and consulting services to leading pharma companies

We come in two flavours


The critical support you need to develop a successful value assessment and launch strategy.

Digital products

Time-saving digital solutions that help you launch your brand to the right patients, at the right price, at the right time.

We look forward to meeting you

ACCESS 2024 is a great opportunity to share ideas. Block some time for a product demo or chat with our P&MA experts. We look forward to seeing you in Miami.